导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.24% | 305/1050 |
| 近一周 | -0.89% | 432/1104 |
| 近一月 | -2.56% | 454/1103 |
| 近一季 | -16.79% | 904/1092 |
| 近半年 | 2.58% | 380/1070 |
| 近一年 | 17.90% | 278/1018 |
| 近两年 | 59.88% | 441/926 |
| 近三年 | 44.46% | 310/834 |
| 成立以来 | 59.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.60% 371/1070 |
45.08% 246/1101 |
- - |
- - |
| 2025 | 7.61% 854/1065 |
-3.68% 978/1014 |
2.92% 441/1038 |
2.03% 974/1050 |
6.37% 96/1065 |
| 2024 | 21.78% 75/1011 |
0.05% 308/960 |
-0.74% 356/983 |
16.80% 148/991 |
4.97% 141/1011 |
| 2023 | -4.25% 183/952 |
7.60% 191/880 |
-2.93% 368/895 |
-6.54% 393/915 |
-1.91% 223/952 |
| 2022 | -21.14% 376/867 |
-13.52% 200/773 |
-0.63% 712/806 |
-8.32% 157/845 |
0.10% 440/867 |
| 2021 | 4.83% 303/740 |
-8.88% 466/580 |
5.86% 451/659 |
-1.27% 239/704 |
10.08% 82/740 |
| 2020 | 37.04% 318/554 |
-0.87% 181/419 |
24.29% 205/466 |
5.50% 357/517 |
5.44% 428/554 |
| 2019 | 36.46% 249/410 |
24.91% 710/1146 |
-0.86% 437/1228 |
1.56% 287/390 |
8.50% 220/410 |
| 2018 | -29.96% 213/349 |
- - |
-13.87% 709/990 |
-9.25% 717/1000 |
-11.51% 475/1080 |
| 2017 | 10.81% 129/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 建信多因子量化股票 VS. 东吴新产业精选股票A(580008) |